AI assistant
Orchid Pharma Limited — Call Transcript 2023
Nov 2, 2023
60526_rns_2023-11-02_3eb9d2dc-bba6-438e-b5b2-68ae22501ae7.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [552 x 66] intentionally omitted <==
November 02, 2023
National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai400001 Symbol: ORCHPHARMA Scrip Code: 524372
Subject : Intimation of Schedule of Analyst/ Investor Earning Call – Orchid Pharma Limited (“the Company”)
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an Investor Earning Call is scheduled to be held on Monday, November 06, 2023 at 06:00 P.M. (IST) to discuss the financial performance of the Company for quarter and half year ended September 30, 2023.
The schedule of the Investor Earning Call is enclosed herewith. The aforesaid information will also be hosted on the Company’s website at www.orchidpharma.com
Note: The schedule may undergo change due to exigencies on the part of Investors/Analysts/Company.
You are requested to take the above on record.
Thanking You, For Orchid Pharma Limited
MARINA Digitally signed by MARINA PETER PETER Date: 2023.11.02 18:05:54 +05'30' Marina Peter Company Secretary & Compliance Officer Encl. as above
==> picture [519 x 12] intentionally omitted <==
Orchid Pharma Limited Regd. Office: Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Alathur, Chengalpattu Dist.- 603110, Tamil Nadu, India Phone : (91)-44- 2744 4471/72/73 Email: [email protected] Website : www.orchidpharma.com CIN: L24222TN1992PLC022994
==> picture [261 x 45] intentionally omitted <==
SYSTEMATIX INSTITUTIONAL EQUITIES
Invites you to participate in
Q2FY24 Results Conference Call of
==> picture [127 x 42] intentionally omitted <==
Orchid Pharma Limited
On Monday, 06[th] November 2023 at 06:00 PM (IST)
The management will be represented by
Mr. Manish Dhanuka Mr. Mridul Dhanuka Mr. Sunil Kumar Gupta Managing Director Whole Time Director Chief Financial Officer
Dial-in-number
| LocationDial Number | LocationToll Free Number |
|---|---|
| Primary Number+91 22 6280 1297 | USA:1 866 746 2133 |
| UK:0 808 101 1573 | |
| SecondaryNumber+91 22 7115 8198 | Singapore:800 101 2045 |
| Hong Kong:800 964 448 |
Click here for your Diamond Pass™
DiamondPass™ is a Premium Service that enables you to connect to your conference call without having to wait for an operator.
For more information, please contact:
Vishal Manchanda Mrunal Pawar
Contact No: +919737437148 Contact No: + 91 22 6704 8088 [email protected] [email protected]